Literature DB >> 8411347

Productive infection of a cervical epithelial cell line with human immunodeficiency virus: implications for sexual transmission.

X Tan1, R Pearce-Pratt, D M Phillips.   

Abstract

The human cervix-derived epithelial cell line (ME180) used in this study displays a characteristics epithelial morphology, including numerous desmosomes, tonofilaments, and epidermal filaments. When T-cell lines infected with human immunodeficiency virus (HIV) are added to epithelial cultures, they rapidly adhere to the epithelial monolayer. Within a few minutes, the T cells shed numerous virions into narrow spaces formed between the epithelial cell and the adherent T cells. Virions subsequently enter the ME180 cells via large vesicles. A few days after infection, cytopathic effects and syncytium formation were observed. Infected clones of ME180 cells have remained infected for 8 months. p24 enzyme-linked immunosorbent assay and infectivity assays show that one subclone of the cell line produces virus titers equivalent to those of high-secreting HIV-infected T-cell lines. Electron microscopy reveals numerous virions budding from both the basal and apical surfaces of the epithelium. These observations suggest that cervical epithelium has the potential to serve as a site of HIV infection.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8411347      PMCID: PMC238080     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  24 in total

1.  Some properties of a new epithelial cell line of human origin.

Authors:  J A Sykes; J Whitescarver; P Jernstrom; J F Nolan; P Byatt
Journal:  J Natl Cancer Inst       Date:  1970-07       Impact factor: 13.506

Review 2.  Heterosexual transmission of acquired immunodeficiency syndrome: international perspectives and national projections.

Authors:  N S Padian
Journal:  Rev Infect Dis       Date:  1987 Sep-Oct

Review 3.  The transmission of AIDS: the case of the infected cell.

Authors:  J A Levy
Journal:  JAMA       Date:  1988-05-27       Impact factor: 56.272

4.  HIV infection of rectal mucosa.

Authors:  J M Mathijs; M Hing; J Grierson; D E Dwyer; C Goldschmidt; D A Cooper; A L Cunningham
Journal:  Lancet       Date:  1988-05-14       Impact factor: 79.321

5.  Immunohistologic characterization and quantitation of leukocyte subpopulations in human semen.

Authors:  H Wolff; D J Anderson
Journal:  Fertil Steril       Date:  1988-03       Impact factor: 7.329

6.  Isolation of HTLV-III/LAV from cervical secretions of women at risk for AIDS.

Authors:  M W Vogt; D J Witt; D E Craven; R Byington; D F Crawford; R T Schooley; M S Hirsch
Journal:  Lancet       Date:  1986-03-08       Impact factor: 79.321

7.  Isolation of AIDS-associated retrovirus from genital secretions of women with antibodies to the virus.

Authors:  C B Wofsy; J B Cohen; L B Hauer; N S Padian; B A Michaelis; L A Evans; J A Levy
Journal:  Lancet       Date:  1986-03-08       Impact factor: 79.321

8.  Replication and apical budding of HIV-1 in mucous-secreting colonic epithelial cells.

Authors:  N Yahi; S Baghdiguian; C Bolmont; J Fantini
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1992-10

9.  Human immunodeficiency virus detected in bowel epithelium from patients with gastrointestinal symptoms.

Authors:  J A Nelson; C A Wiley; C Reynolds-Kohler; C E Reese; W Margaretten; J A Levy
Journal:  Lancet       Date:  1988-02-06       Impact factor: 79.321

10.  Productive, persistent infection of human colorectal cell lines with human immunodeficiency virus.

Authors:  A Adachi; S Koenig; H E Gendelman; D Daugherty; S Gattoni-Celli; A S Fauci; M A Martin
Journal:  J Virol       Date:  1987-01       Impact factor: 5.103

View more
  32 in total

Review 1.  Antiretroviral-drug concentrations in semen: implications for sexual transmission of human immunodeficiency virus type 1.

Authors:  A D Kashuba; J R Dyer; L M Kramer; R H Raasch; J J Eron; M S Cohen
Journal:  Antimicrob Agents Chemother       Date:  1999-08       Impact factor: 5.191

Review 2.  Directed egress of animal viruses promotes cell-to-cell spread.

Authors:  David C Johnson; Mary T Huber
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

3.  The Development of Microbicides for Clinical Use to Prevent Sexually Transmitted Diseases.

Authors:  David M. Phillips; Robin A. Maguire
Journal:  Curr Infect Dis Rep       Date:  2002-04       Impact factor: 3.725

4.  Active and selective transcytosis of cell-free human immunodeficiency virus through a tight polarized monolayer of human endometrial cells.

Authors:  H Hocini; P Becquart; H Bouhlal; N Chomont; P Ancuta; M D Kazatchkine; L Bélec
Journal:  J Virol       Date:  2001-06       Impact factor: 5.103

5.  Vaginal formulations of carrageenan protect mice from herpes simplex virus infection.

Authors:  V R Zacharopoulos; D M Phillips
Journal:  Clin Diagn Lab Immunol       Date:  1997-07

Review 6.  Interactions between HIV-1 and mucosal cells in the female reproductive tract.

Authors:  Ruizhong Shen; Holly E Richter; Phillip D Smith
Journal:  Am J Reprod Immunol       Date:  2014-04-01       Impact factor: 3.886

7.  Vaginal transmission of cell-associated HIV-1 in the mouse is blocked by a topical, membrane-modifying agent.

Authors:  Kristen V Khanna; Kevin J Whaley; Larry Zeitlin; Thomas R Moench; Karim Mehrazar; Richard A Cone; Zhaohao Liao; James E K Hildreth; Timothy E Hoen; Leonard Shultz; Richard B Markham
Journal:  J Clin Invest       Date:  2002-01       Impact factor: 14.808

8.  The intracytoplasmic domain of gp41 mediates polarized budding of human immunodeficiency virus type 1 in MDCK cells.

Authors:  R Lodge; H Göttlinger; D Gabuzda; E A Cohen; G Lemay
Journal:  J Virol       Date:  1994-08       Impact factor: 5.103

9.  Sulfated polyanions block Chlamydia trachomatis infection of cervix-derived human epithelia.

Authors:  F R Zaretzky; R Pearce-Pratt; D M Phillips
Journal:  Infect Immun       Date:  1995-09       Impact factor: 3.441

10.  Infection of vaginal and colonic epithelial cells by the human immunodeficiency virus type 1 is neutralized by antibodies raised against conserved epitopes in the envelope glycoprotein gp120.

Authors:  Y Furuta; K Eriksson; B Svennerholm; P Fredman; P Horal; S Jeansson; A Vahlne; J Holmgren; C Czerkinsky
Journal:  Proc Natl Acad Sci U S A       Date:  1994-12-20       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.